1. Home
  2. JHS vs ACOG Comparison

JHS vs ACOG Comparison

Compare JHS & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo John Hancock Income Securities Trust

JHS

John Hancock Income Securities Trust

HOLD

Current Price

$11.01

Market Cap

136.5M

Sector

Finance

ML Signal

HOLD

Logo Alpha Cognition Inc.

ACOG

Alpha Cognition Inc.

HOLD

Current Price

$5.79

Market Cap

129.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
JHS
ACOG
Founded
N/A
2000
Country
United States
Canada
Employees
N/A
N/A
Industry
Finance Companies
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
136.5M
129.4M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
JHS
ACOG
Price
$11.01
$5.79
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$18.00
AVG Volume (30 Days)
17.6K
57.2K
Earning Date
01-01-0001
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$132.35
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.62
$3.75
52 Week High
$12.09
$10.88

Technical Indicators

Market Signals
Indicator
JHS
ACOG
Relative Strength Index (RSI) 24.22 51.49
Support Level $11.01 $5.16
Resistance Level $11.40 $6.67
Average True Range (ATR) 0.10 0.34
MACD -0.03 -0.02
Stochastic Oscillator 4.62 51.00

Price Performance

Historical Comparison
JHS
ACOG

About JHS John Hancock Income Securities Trust

John Hancock Income Securities Trust is a United States-based closed-end diversified management investment company. Its main objective is to generate a high level of current income consistent with prudent investment risk. The fund invests its net assets (plus borrowings for investment purposes) in income securities, consisting of marketable corporate debt securities, governmental obligations, and cash and commercial paper. A majority of its net assets are invested in debt securities that are rated, at the time of acquisition, investment-grade or in unrated securities determined by the Fund's investment advisor or subadvisor to be of comparable credit quality.

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Share on Social Networks: